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Abstract This paper aims to estimate the service and
social costs of headache presenting in primary care and to
identify predictors of headache costs. Patients were
recruited from GP practices in England and service use and
lost employment recorded. Predictors of cost were identi-
ﬁed using regression models. Service and social costs were
available on 288 and 282 patients, respectively. Average
service costs over 3 months were £117 whilst total costs
(including lost production) were £582. Patients referred to
neurologists had service costs that were £82 higher than
those not referred (90% CI £36–£128). Costs including lost
employment were higher by £150, but this was not sig-
niﬁcant (90% CI -£139–£439). The annual mean service
and social costs, weighted to represent population rates of
referral, were £468 and £2328, respectively. Higher costs
were signiﬁcantly related to pain. Age was linked to higher
service costs and lower social costs. The ﬁgures extrapo-
lated to the whole of the UK suggest £956 million due to
service use and £4.8 billion including lost employment.
These are likely to be underestimates because many people
experiencing headaches do not consult their GP.
Keywords Economics  Costs analysis  Primary care 
Headache
Introduction
Headache, including migraine, is a common problem and is
in the top ten causes of disability [1]. It is usually self-
managed, but had been estimated to account for 44 consul-
tations per 1,000 people inprimarycare.Similarly,although
GPs refer to neurologists only 2–3% of patients consulting
for headaches, this condition accounts for up to one-third of
new specialist neurology appointments in the UK [2].
Clearly headache can cause distress for individuals and
limit their activities. This, combined with the demand for
treatment, suggests that there is an economic burden
associated with headache [3]. Direct costs are due to the
use of services, such as doctor time and medication in order
to treat the headache. Indirect costs are caused by the
impact that headache has on the activities of the patient,
and are typically conﬁned to the effect on productivity.
A number of studies have sought to estimate headache
(mainly migraine) costs, but these show considerable
variations in methods and ﬁndings [4]. In Europe, the costs
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DOI 10.1007/s10194-011-0362-0of migraine and other headaches have been estimated to be
€590 per person, of which 94% was due to indirect costs
[5]. In the United States, the total cost of migraine was
estimated at $14.4 billion, again with most (93%) due to
indirect costs [6]. A recent review of studies from the USA
has also suggested that the indirect costs of migraine out-
weigh the direct costs, although with the difference slightly
less compared to the above two studies [7]. In another
study, the costs of treating migraine in Brazil have been
estimated at $140 million, with one-third of this due to
primary care services [8].
Most studies have reported costs for migraine, but this is
only a subset of all headaches treated in primary care set-
tings. We have previously compared the demographic and
clinical characteristics of patients referred by GPs to neu-
rologists with those remaining in primary care. It was
found that referral to neurologists was not related to
headache severity, but was associated with an increased
number of consultations with GPs and increased fear and
anxiety expressed by patients regarding their headaches, as
well as with GPs lack of clinical conﬁdence and patient
pressure [9, 10]. The aims of this paper are to: (1) measure
the service use and costs for people with headache pre-
senting in primary care, (2) compare service use and costs
for patients referred and not referred to specialists, and (3)
identify patient characteristics associated with costs.
Method
This was a primary care-based study set in England and the
study methodology has been described in detail elsewhere
[9]. Patients were recruited from 18 general practices in the
south Thames region––a region covering urban and rural
areas. The number of patients aged 18–75 registered with
GPs was around 141,100. GP practices were recruited over
a 1-year period. As GPs only refer a small proportion of
patients to specialists, it was decided to over-sample these.
Consequently, any patient referred to specialist care during
a 1-year period was eligible for the ‘referred’ group, whilst
patients presenting with headache during a 7-week period
and who remained under the care of the GP (a far more
common scenario) were identiﬁed by someone in each
practice and were eligible for inclusion in the ‘consulted but
non-referred group’. For inclusion, headache was classiﬁed
according to diagnostic codes used by UK primary care
practices (i.e. Read Codes). Patients were potentially
included if the diagnostic codes referred to ‘headache’ or
‘migraine’. Patients were excluded if there were secondary
causes of the headache, if the patient was unable to par-
ticipate in the interviews due to cognitive impairment, or if
they were unable to read and/or write English. Informed
written consent was obtained from participants.
Eligible patients were invited to be interviewed by
research workers in their homes or at the general practice.
The interviews consisted of a number of measures including
the migraine disability assessment score (MIDAS) [11], the
Headache Impact test (HIT)-6 [6, 12] the Hospital Anxiety
and Depression Scale (HADS) [13], and the Revised Illness
Perception Questionnaire (IPQ-R) [14]. These measures are
described in detail by Ridsdale et al. [9]. Seven subscales
from the IPQ-R were used in the analyses: timeline acute-
chronic, timeline cyclic, consequences (where high scores
represent strong beliefs about the chronicity, duration and
impact of headache), personal control, treatment control,
illness coherence, and emotion (where high scores represent
strong beliefs about how well the individual believes that
they or formal treatments can control headaches and how
well the person understands and is troubled emotionally by
their headache disorder).
Service use and costs
It is important to take a comprehensive approach when
estimating the economic consequences of a particular
condition [15]. Headache is no exception, as patients will
potentially be accessing a range of different services and
may also take time off work. A societal perspective was
adopted in this study. We collected information on whether
speciﬁc services had been used in the previous 3 months,
and if so how many times. The services included were:
contacts with general practitioners (GPs), neurologists,
other medical specialists, contacts with other professionals
(including complementary healthcare), scans undertaken
(MRIs and CTs), and prescribed medication. For scans and
GP contacts we asked about the number of times these had
been received for headache and how many for other rea-
sons. Unit costs were attached to the information on service
use using nationally applicable ﬁgures [16, 17].
Productivity costs
Headache can have an impact through people taking time
off work, or having reduced work effectiveness. The
MIDAS questionnaire includes two questions covering the
effect of lost work time due to headache. The ﬁrst of these
asks for the number of whole days lost from work in the
past 3 months. The second asks for the number of days
where productivity is reduced by more than 50%. In the
absence of further information, we have conservatively
assumed this to be equal to half-a-day’s lost work. The
economic cost of lost work time was calculated by multi-
plying the lost days by the earnings that patients in the
sample received (calculated as a daily ﬁgure). Not all
patients stated their earnings and in these cases we obtained
average ﬁgures for their job type and gender from ofﬁcial
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123data [18]. Where the patients stated that they were working,
but did not provide information on their earnings or job
type, we used a gender-speciﬁc average based on the other
sample members. There is some controversy about the best
approach to take in calculating the productivity costs. In
times of high unemployment, it may be that prolonged
absence from work does not result in a cost because
someone else can be taken on. However, with headache it
is more likely that lost work time will be sporadic and
short-term and replacement by someone else would be rare.
A further area of contention is the use of the wage rate as
the value of lost work. This assumes that wages reﬂect true
economic value, but due to market imperfections this may
of course not be true. Given these issues, the resulting
productivity costs must be treated with caution.
Analysis
Service use and costs were reported for each group. The
overall costs are not representative of the population of
people consulting GPs due to the overrepresentation of
those referred to specialists. Therefore, weighted costs
were also computed, based on the ﬁnding by Latinovic
et al. [2] that over a year 2% of consultations result in a
referral to a neurologist. The signiﬁcance of the difference
in total costs with and without productivity costs was
assessed using regression models. Such models allow the
impact of independent variables (in this case being referred
or not) on a dependent variable (cost) to be determined. We
constructed 90% conﬁdence intervals partly because the
analysis was exploratory and also because we recognised
that different levels of risk may be acceptable when
assessing cost differences compared with comparing clin-
ical differences.
Further regression models were then constructed to
identify the demographic and clinical characteristics that
were associated with differences in costs in addition to any
difference due to whether the patient was referred or not.
Independent variables in the model related to headache
severity (number of headache-related symptoms, severity
of pain, need to lie down when headaches occur, feeling
fed up due to pain), psychological distress (anxiety and
depression scores from HADS) [19], illness perception
subscales, age, gender, and the referred/not referred vari-
able. The total score from the HIT-6 was not used as some
items directly relate to lost work time, which has already
been included in the costs. Some variables had missing
values and, therefore, we used imputation methods using
the other variables (plus whether the patients considered
the headaches to be psychological in cause) in Stata v10 to
estimate these values. Because we oversampled patients
who were referred we adjusted the conﬁdence intervals
around the regression coefﬁcients by again weighting the
observations. If we again assume that 98% of patients do
not get referred then the weight for each non-referred
patient is 0.384 (i.e. 98 divided by 255 patients) and the
weight for each referred patient is 0.042 (i.e. 2 divided by
48 patients).
Results
During the sampling periods there were 533 patients who
consulted a GP for headache and a further 93 who were
referred to secondary care services. Of these 626 patients,
569 met inclusion criteria and 303 consented to take part
(255 non-referred, 48 referred). These patients were pre-
dominantly female (71% of non-referred patients, 64%
referred patients) and of similar mean age (39 vs. 41).
Ridsdale et al. [9] show that the two groups do not differ
signiﬁcantly in terms of MIDAS, HIT-6, or HADS scores.
Most patients had consulted their GP during the previ-
ous 3 months, but for the majority this was not due to
headache (Table 1). The average costs of GP contacts for
all reasons and speciﬁcally for headache were higher for
those who had been referred to specialists. A small number
of patients in the non-referred group did have neurologist
contacts during the previous 3 months, possibly for other
conditions, whereas one quarter of the referred patients had
seen neurologists. Most patients in both groups were taking
some form of medication that was likely to be headache
related. MRI or CT scans were more likely to have been
received by referred patients.
The mean service and total costs for the whole sample
are £128 and £601, respectively. For the non-referred
patients the ﬁgures are £115 and £579, respectively, whilst
for those referred they are £197 and £729, respectively. If
we weight the costs for non-referred and referred patients
by 0.98 and 0.02, respectively, the mean service cost
becomes £117 whilst the mean total cost is £582. If rep-
resentative, this would suggest annual service costs of £468
and total costs of £2,328 per person.
Mean service costs (i.e. excluding lost productivity) for
the 3-month period were £82 higher in the referred group, a
difference that was statistically signiﬁcant (90% CI £36–
£128).Thosewhowerereferredalsohadmoretimeoffwork
due to headache and this increased the cost difference to
£150. However, there was substantial variation in lost work
time and this cost difference was not statistically signiﬁcant
(90%CI-£139–£439).Productivitycostsaccountedfor81%
ofthecostsinthenon-referredgroupand72%ofthecostsin
the referred group.
Figures 1 and 2 show the variation in the service costs
and total costs. Ten percent of patients accounted for 42
and 57% of service costs and total (including lost pro-
duction) costs, respectively. The ﬁrst regression model
J Headache Pain (2011) 12:617–623 619
123showed that after controlling for demographic and clinical
characteristics service costs were on average £55 higher for
patients (i.e. lower than the unadjusted ﬁgure of £82) who
were referred to specialists, and this was statistically sig-
niﬁcant (Table 2). Higher service costs were also associ-
ated with being male (£44 higher costs than for women),
age (each year accounting for an increase in costs of £2),
the level of pain they experienced, and how substantially
the patient believed the consequences of their headache
disorder to be. This model could explain 17% of cost
variation. Costs including lost work time were signiﬁcantly
lower for older patients (on average by £10 for each extra
year of age), higher for patients with more anxiety (a one
unit increase associated with costs that were £52 higher),
and higher for patients with stronger beliefs that their
headache can be controlled by treatment. Costs were again
associated with pain. The model could explain 7% of
variation in cost.
Men had lower total costs than women, although the
difference was not signiﬁcant. This result was surprising as
the data revealed that men had slightly more days when
they could not work (according to the MIDAS questions)
than women (4.5 vs. 4.0 days). Also daily wages were
slightly higher for men (£127 vs. £103). Further analyses
did though explain the lower total costs for men. For
women in employment, there was a positive correlation
(0.15) between their daily wages and days off work.
However, for men the correlation was negative and larger
in magnitude (-0.32). This implies that men who had
days off work were likely to be paid less and, therefore,
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123this reduces the overall cost of lost employment, and
consequently total costs, compared to women.
Discussion
Headache is a common health problem affecting over
90% of the population during their lives. Most people
self-manage symptoms with over-the-counter medication,
with 4% of adults consulting their GP for headache each
year [2]. If we extrapolate the 3-month costs then the annual
services costs are £468 and the annual total costs are £2,328.
When we consider the number of people presenting with
headache the costs are substantial. If we apply the above
ﬁgure of 4% of people consulting their GP with headache to
the UK population aged 15 and over (which in 2009 was
estimated at 51.1 million [20]), then the service costs for
people consulting with headache are £956 million and the
total costs including lost production are £4.8 billion.
The results presented in this paper are of importance to a
specialist audience because, whilst most patients with
headache receive care from GPs, patients with headache
account for around one-third of referrals to neurologists
[2]. In addition, GPs are increasingly developing special
interests including in headache and, therefore, the distinc-
tion between ‘specialists’ and ‘generalists’ may be coming
less clear [21].
Clearly, the main economic effect of headache is the
impact that it has on productivity. We found that 81% of
the total costs of headache were due to lost work time. This
may be an underestimate of the broader social costs––there
would clearly be an impact on work in the home also, as
well as on leisure activities. Other studies have found
higher proportions accounted for by indirect costs [5, 6],
and the difference may be due to the primary care focus of
this study and the fact that we included all headache types.
In Denmark, headache has been shown to account for 20%
of sickness absence [22].
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Table 2 Weighted regression
of analysis of service costs and
total costs
Costs in 2003/4 £s
Service costs Total costs
Coefﬁcient 90% CI Coefﬁcient 90% CI
Referred 55 2 to 108 121 -177 to 418
Male 44 1 to 88 -70 -376 to 235
Age 2 1 to 4 -10 -19 to -2
Anxiety score 6 0 to 11 52 11 to 94
Depression score 2 -5t o1 0 -12 -66 to 41
Severity of pain (HIT 1) 12 2 to 23 96 6 to 185
Need to lie down (HIT 3) -6 -18 to 6 -44 -117 to 30
Feel fed up due to pain (HIT 5) 1 -7t o1 0 2 4 -53 to 102
IPQ-R number of headache-related symptoms 1 -2t o5 -1 -27 to 25
IPQ-R timeline acute-chronic -2 -6t o3 1 1 -29 to 50
IPQ-R timeline cyclic 0 -5t o5 -39 -87 to 9
IPQ-R consequences 5 1 to 10 22 -11 to 55
IPQ-R personal control -3 -8t o2 1 2 -31 to 55
IPQ-R treatment control 3 -3 to 10 55 4 to 106
IPQ-R illness coherence -3 -7t o0 -3 -32 to 26
IPQ-R emotional representation 1 -4t o6 -7 -45 to 31
Constant -218 -1285
R
2 = 0.1668 R
2 = 0.0729
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123Service costs were found to be higher for patients who
had been referred to secondary care services. These extra
costs consisted of more GP contacts, contacts with neu-
rologists and scans. The study found that one-quarter of the
referred sample had received input from neurologists by
the time the ﬁrst questionnaire was administered. There-
fore, the cost difference would be even greater in the longer
term once all referred patients had received specialist
advice or care.
The regression model found that higher service costs
were signiﬁcantly associated with age, which likely reﬂects
increasing morbidity with age. Greater pain severity was
also associated with higher costs. The only IPQ-R subscale
that was signiﬁcantly related to service cost was beliefs
about the consequences of the headache. The more sub-
stantial the consequences were perceived to be, the higher
the costs. Referrals to neurologists for headache has been
associated with dissatisfaction in up to one-third of patients
[23], and this is possibly because underlying anxieties have
not been addressed. Cognitive-behavioural approaches may
be appropriate in these circumstances, and it will be
worthwhile to explore and develop approaches which
include such techniques [24].
Each of the above relationships could be expected and
indicate that patients with higher levels of need are in
receipt of most resources. Total costs were, however,
inversely related to age, which is due to the fact that older
patients are less likely to be in employment and to expe-
rience lost work days. As before, pain severity was asso-
ciated with higher costs.
The weighted mean cost for neurologist contacts was
only £9, but across the population this would equate to
around £18 million. In a recent study, we have shown that
if GPs receive speciﬁc training in headache management,
then patients can be seen for a lower cost, and they are
more satisﬁed with the service [21]. However, for younger
patients referral may be more socially cost-effective pro-
vided it does lead to amelioration of symptoms which
cause distress and disability. This is worth testing, and
might justify increased investment in providing more
intermediate or specialist services.
Limitations
The study has a number of limitations. First, a limited
number of services were included in the costings and as
such the ﬁgures may be an underestimate. Second, we have
included GP and neurologist contacts and interventions
used by people with headache, but not necessarily due to
headache. It is clear that comorbidity is common and does
have a cost impact [25], but it is problematic to disentangle
this effect from costs unrelated to headache. Third, patients
were recruited over a 1-year period and if they were
towards the end of this period then they may not yet have
seen a neurologist even if referred. Conversely, some
patients may have been deﬁned as non-referrals, but may
actually have seen a neurologist following a referral before
the recruitment period. Fourth, the sample only consists of
those who contacted their GP. Substantial numbers of
people do not seek treatment and, whilst this means they do
not incur service costs, it is most likely that a number take
time off work. Fifth, days where the productivity was
reduced by at least 50% were costed using half of the daily
wage rate. This approach, therefore, possibly underesti-
mates the productivity costs. In addition, we have not
included days where the productivity was reduced, but by
less than 50%. This seems reasonable and the productivity
costs remain substantial.
Conclusions
This paper has found that the mean costs associated with
headache presenting in primary care are £601 over a
3-month period. Most of this is due to lost employment.
Service costs are signiﬁcantly higher for patients referred
to neurologists and those with greater symptom severity.
Acknowledgments We thank the following practices: Brigstock
Medical Centre, Brixton Group Practice, Central Surgery (Surbiton),
Cheam Family Practice, Jenner Health Centre, Lambeth Walk Group
Practice, Manor Brook Medical Centre, Morden Hall Medical Centre,
Morden Hill Group Practice, Rushey Green Group Practice, Selsdon
Park Medical Practice, the Canbury Medical Centre, the Green Sur-
gery (Twickenham), the Hurley Clinic, the Medical Centre at New
Cross, the Vanbrugh Group Practice, The Woodcote Medical Prac-
tice, and Wrythe Green Surgery. We also thank Caroline Morse, Dr
Claire Rutter, STARNet and Professor Roger Jones for their contri-
butions to the study, and Adrienne Knight for preparing the manu-
script. The study was funded by the Medical Research Council.
Conﬂict of interest None.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution and reproduction in any medium, provided the original
author(s) and source are credited.
References
1. Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton RB, Scher
AI, Steiner TJ, Zwart JA (2007) The global burden of headache: a
documentation of headache prevalence and disability worldwide.
Cephalalgia 27:193–210
2. Latinovic R, Gulliford M, Ridsdale L (2006) Headache and
migraine in primary care: consultation, prescription, and referral
rates in a large population. J Neurol Neurosurg Psychiatry
77:385–387
3. Mennini FS, Gitto L, Martelletti P (2008) Improving care through
health economics analyses: cost of illness and headache. J Head-
ache Pain 9:199–206
622 J Headache Pain (2011) 12:617–623
1234. Berg J (2004) Economic evidence in migraine and other head-
aches: a review. Eur J Health Econ 5(Suppl 1):S43–S54
5. Berg J, Stovner LJ (2005) Cost of migraine and other headaches
in Europe. Eur J Neurol 12(Suppl 1):59–62
6. Hu XH, Markson LE, Lipton RB, Stewart WF, Merger ML
(1999) Burden of migraine in the United States: disability and
economic costs. Arch Intern Med 159:813–818
7. Hazard E, Munakata J, Bigal ME, Rupnow MFT, Lipton RB
(2009) The burden of migraine in the United States: current and
emerging perspectives on disease management and economic
analysis. Value in Health 12:55–64
8. Bigal ME, Rapoport AM, Bordini CA, Tepper SJ, Sheftell FD,
Speciali JG (2003) Burden of migraine in Brazil: estimate of cost
of migraine to the public health system and an analytical study of
the cost-effectiveness of a stratiﬁed model of care. Headache
43:742–754
9. Ridsdale L, Clark LV, Dowson AJ, Goldstein LH, Jenkins L,
McCrone P, Morgan M, Seed PT (2007) How do patients referred
to neurologists for headache differ from those managed in
primary care? Br J Gen Pract 57:388–395
10. Morgan M, Jenkins L, Ridsdale L (2007) Patient pressure for
referral for headache: a qualitative study of GPs’ referral
behaviour. Br J Gen Pract 57:29–35
11. Stewart WF, Lipton RB, Whyte J, Dowson A, Kolodner K,
Liberman JN, Sawyer J (1999) An international study to assess
reliability of the Migraine Disability Assessment (MIDAS) score.
Neurology 53:988–994
12. Kosinski M, Bayliss MS, Bjorner JB, Ware JE Jr, Garber WH,
Batenhorst A (2003) A six-item short-form survey for measuring
headache impact: the HIT-6. Qual Life Res 12:963–974
13. Wilkinson MJB, Barczak P (1988) Psychiatric screening in
general practice: comparison of the General Health Questionnaire
and the Hospital and Anxiety and Depression Scale. Br J Gen
Pract 38:311–313
14. Moss-Morris R, Weinman J, Petrie KJ, Horne R, Cameron L,
Buick D (2002) The Revised Illness Perception Questionnaire
(IPQ-R). Psychol Health 17:1–16
15. Beecham J, Knapp M (1990) Costing mental health services.
Psychol Med 20:893–908
16. Curtis L, Netten A (2004) Unit costs of health and social care.
PSSRU, Canterbury
17. Department of Health (2005) NHS reference costs 2003–2004.
http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/
PublicationsPolicyAndGuidance/DH_4105545. Accessed 12 Mar
2010
18. Nationals Statistics (2004). Annual survey of Hours and Earn-
ings 2003. http://www.statistics.gov.uk/statbase/Product.asp?vlnk=
13107. Accessed 15 Jun 2011
19. Crawford JR, Henry JD, Crombie C, Taylor EP (2001) Normative
data for the HADS from a large non-clinical sample. Br J Clin
Psychol 40:429–434
20. Government Actuary Department. Population projections by
the Ofﬁce for National Statistics. http://www.gad.gov.uk/Demo
graphy%20Data/Population/index.aspx?y=2006&v=Principal&
dataCountry=uk&chkDataTable=cc_5y. Accessed 13 Oct 2009
21. Ridsdale L, Doherty J, McCrone P, Seed P (2008) A new prac-
titioner with special interest headache service: observational
study. Br J Gen Pract 58:478–483
22. Rasmussen BK, Jensen R, Olesen J (1992) Impact of headache on
sickness absence and utilisation of medical services: a Danish
population study. J Epidemiol Community Health 46:443–446
23. Fitzpatrick Hopkins, Harvard-Watts O (1983) Social dimensions
of healing: a longitudinal study of outcomes of medical man-
agement of headaches. Soc Sci Med 17:501–510
24. Symvoulakis E, Clark L, Dowson A, Jones R, Ridsdale L (2007)
Headache: A suitable case for behavioural treatment in primary
care. Br J Gen Pract 57:231–237
25. Dartigues JF, Michel P, Henry P (2003) The economic burden of
headache. In: Olesen J, Steiner TJ, Lipton RB (eds) Reducing
the burden of headache. Oxford University Press, Oxford,
pp 218–222
J Headache Pain (2011) 12:617–623 623
123